Sign-up here to receive Disease Progression Monitor updates. Sign-up Related Industry Life Sciences & Pharma
Organization & Performance Published Articles Working From Home after COVID-19: businesses need to allow flexibility, or they will lose… May 4, 2020 As businesses consider the likely shape of recovery from lockdown, we have researched the impact of the current enforced experience of working from home…
Life Sciences & Pharma Executive Insights Maximizing Oncology Success Through World-Class Guideline and Compendia Strategies February 18, 2020 National Comprehensive Cancer Network (NCCN) recommendations are considered to be the gold standard for public and private insurers to use in making…
Life Sciences & Pharma COVID-19 COVID-19 Implications for Asia-Pacific Healthcare Ecosystems May 14, 2020 It is essential for healthcare ecosystem stakeholders across APAC to leverage opportunities that have arisen and prepare for the new norm.
Organization & Performance COVID-19 Agile Transformation Part 1: Unlocking the Benefits of Agile May 6, 2020 Executives and leadership teams are looking to agile as a methodology for driving organisational transformation, and as a strategy to address three…
Life Sciences & Pharma Executive Insights Managing Non-Core Assets: Innovative Funding Models for Biopharma Companies May 15, 2020 We discuss some of the innovative funding models available and identify the key strategies for optimizing these types of deals.
Strategy COVID-19 Global Situation Report Insights: Edition 2 June 9, 2020 The L.E.K. Global Situation Report is a uniquely rich, current, and customisable collection of indicators that provide a powerful recovery planning aide.
